FDA Inspection
Products By O2, IncProducts By O2, Inc – FDA Inspection, Oct 23, 2023
Record Details
This FDA Inspection record concerns Products By O2, Inc, with an inspection on October 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c1643c02-72d0-4a14-b51a-609b83ed792b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1220843
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
21- 21 CFR 211.122(d)Label storage access limited to authorized personnel
- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.170(b)Reserve samples identified, representative, stored
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.52Washing and toilet facilities are deficient
- 21 CFR 211.100(a)Approval and review of procedures
Showing 10 of 21 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Products By O2, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 16, 2017 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
Other documents for Products By O2, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.